Search Results - shi-long+lu

1 Results

Sort By:

Bivalent EGF- Diphtheria Fusion Toxin For The Treatment Of Head And Neck Cancer

Head and neck cancers (HNC) are the 9th most common malignancy and 6th most deadly worldwide. 80% of HNCs are squamous cell carcinomas (HNSCC). The overall response and survival rate for HNSCC are quite low, and there is a dramatic need for effective and targeted treatments of HNSCC. EGF Receptor (EGFR) is highly expressed in over 90% of HNSCCs, making...

Published: 8/29/2022 | Inventor(s): Zhirui Wang, Shi-Long Lu

Disease Areas Oncology

Category(s): Therapeutics